{"id":1392,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2018-02-08","marketCap":562.363,"name":"Evolus Inc","phone":"19492844555.0","outstanding":56.97,"symbol":"EOLS","website":"https://www.evolus.com","industry":"Pharmaceuticals"},"price":9.58075,"year":2023,"month":11,"day":30,"weekday":"Thursday","title":"Historical Performance of Evolus Inc Stock during Economic Recessions and Recoveries","date":"2023-11-30","url":"/posts/2023/11/30/EOLS","content":[{"section":"Introduction","text":"Evolus Inc is a company that specializes in aesthetic medicine and delivers innovative products for the aesthetic market. To understand the historical performance of Evolus Inc stock during economic recessions and recoveries, we will analyze the stock's performance over the past few economic downturns and subsequent recoveries."},{"section":"2008 Financial Crisis","text":"During the 2008 financial crisis, the global economy experienced a severe recession. Evolus Inc, being a relatively new company, did not exist during this period. Therefore, there isn't any historical stock performance data available for analysis during this specific recession."},{"section":"COVID-19 Pandemic","text":"The COVID-19 pandemic that began in early 2020 led to a significant global economic downturn. Evolus Inc., being an aesthetic medicine company, faced challenges as lockdowns and restrictions impacted elective medical procedures worldwide. The company's stock initially experienced a sharp decline in early 2020 as uncertainty prevailed. However, as the world began to recover, and vaccine distribution increased, Evolus Inc stock showed signs of a potential recovery."},{"section":"Other Economic Recessions and Recoveries","text":"For economic downturns not mentioned above, historical stock performance data for Evolus Inc during those specific periods is not available. As a relatively new company, it may not have experienced prior recessions and recoveries in its stock history."},{"section":"Conclusion","text":"Evolus Inc's historical stock performance during economic recessions and recoveries is limited due to the company's relatively recent establishment. However, during the COVID-19 pandemic, the stock initially suffered but later showed signs of potential recovery as the world progressed towards economic stabilization. It is important to note that past performance may not necessarily indicate future performance, and investors should consider various factors before making investment decisions."}],"tags":["CrossOver55","Long","Pharmaceuticals"],"news":[{"category":"company","date":1699934100,"headline":"Evolus management to meet with Needham","id":123862677,"image":"","symbol":"EOLS","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3211647654"},{"category":"company","date":1699884487,"headline":"Evolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call Transcript","id":123849952,"image":"https://s.yimg.com/ny/api/res/1.2/Ab.KVTAfof_sqyux1AX.Uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/f346b2a045338adf316ad28372a882fb","symbol":"EOLS","publisher":"Yahoo","summary":"Evolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good afternoon, and welcome to the Evolus Third Quarter 2023 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to your host, Mr. Ned Mitchell from Investor Relations. Ned? Ned Mitchell: Thank you, operator, and welcome to everyone […]","url":"https://finance.yahoo.com/news/evolus-inc-nasdaq-eols-q3-140807488.html"},{"category":"company","date":1699654560,"headline":"Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","id":123807189,"image":"https://media.zenfs.com/en/business-wire.com/bc06a1b9e9e8bdd4fcd0aa08bf11e6df","symbol":"EOLS","publisher":"Yahoo","summary":"NEWPORT BEACH, Calif., November 10, 2023--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in October of non-qualified stock options to purchase an aggregate of 63,703 shares of Evolus and an aggregate of 70,320 restricted stock units (RSUs) of the company’s common stock to 8 newly hired non-executive employees of the company (the \"October Grants\"). The Company also is reporting the grant in Nov","url":"https://finance.yahoo.com/news/evolus-reports-inducement-grants-under-221600895.html"},{"category":"company","date":1699594920,"headline":"Evolus Exceeds Expectations: Sustained Growth and Raised Guidance Lead to Buy Rating","id":123799208,"image":"","symbol":"EOLS","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3206208894"},{"category":"company","date":1699447680,"headline":"Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session","id":123727971,"image":"","symbol":"EOLS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202351161"},{"category":"company","date":1699446240,"headline":"Commit To Purchase Evolus At $7.50, Earn 17.9% Annualized Using Options","id":123731585,"image":"","symbol":"EOLS","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202307886"},{"category":"company","date":1699440900,"headline":"Evolus (EOLS) Shares Cross Above 200 DMA","id":123731586,"image":"","symbol":"EOLS","publisher":"Market News Video","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202157846"},{"category":"company","date":1699438020,"headline":"Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday","id":123722920,"image":"","symbol":"EOLS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202081389"},{"category":"company","date":1699434300,"headline":"Durect, Lumos Pharma among healthcare movers","id":123725601,"image":"","symbol":"EOLS","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3201981658"},{"category":"company","date":1699427280,"headline":"12 Health Care Stocks Moving In Wednesday's Pre-Market Session","id":123724987,"image":"","symbol":"EOLS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3201810634"},{"category":"company","date":1699426260,"headline":"Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket","id":123723242,"image":"","symbol":"EOLS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3201789268"},{"category":"company","date":1699391760,"headline":"Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®","id":123706976,"image":"https://media.zenfs.com/en/business-wire.com/23e42e503ac818aefc5d837a4960e694","symbol":"EOLS","publisher":"Yahoo","summary":"NEWPORT BEACH, Calif., November 07, 2023--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported financial results for the third quarter ended September 30, 2023.","url":"https://finance.yahoo.com/news/evolus-reports-record-third-quarter-211600428.html"},{"category":"company","date":1699389925,"headline":"Evolus, Inc. (EOLS) Q3 2023 Earnings Call Transcript","id":123705991,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"EOLS","publisher":"SeekingAlpha","summary":"Evolus, Inc. (NASDAQ:NASDAQ:EOLS) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ETCompany ParticipantsNed Mitchell - IRRui Avelar - Chief...","url":"https://seekingalpha.com/article/4648847-evolus-inc-eols-q3-2023-earnings-call-transcript"},{"category":"company","date":1699357140,"headline":"Promising Results from Evolus’s Jeuveau Formulation Drive Positive Analyst Outlook","id":123731591,"image":"","symbol":"EOLS","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3201427976"},{"category":"company","date":1699335240,"headline":"Fly Intel: After-Hours Movers","id":123705846,"image":"","symbol":"EOLS","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3200681394"},{"category":"company","date":1699335060,"headline":"Analysts’ Top Healthcare Picks: Bioxcel Therapeutics (BTAI), Alphatec Holdings (ATEC)","id":123692094,"image":"","symbol":"EOLS","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3199480009"},{"category":"company","date":1699328760,"headline":"Evolus GAAP EPS of -$0.30 misses by $0.01, revenue of $50M beats by $5.62M","id":123698633,"image":"","symbol":"EOLS","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3200446724"},{"category":"company","date":1699328100,"headline":"12 Health Care Stocks Moving In Tuesday's After-Market Session","id":123697981,"image":"","symbol":"EOLS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3200424623"},{"category":"company","date":1699327140,"headline":"Evolus reports Q3 EPS (30c), consensus (17c)","id":123698640,"image":"","symbol":"EOLS","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3200393724"}]}